GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: Compound A [WO2025119266] | HSK-39297 | HSK39297
Compound class:
Synthetic organic
Comment: Ciprocopan is the INN for a complement factor B (CFB) inhibitor. CFB inhibitors are intended to reduce activation of complement-mediated inflammation by inhibiting formation of C3bBb alternative pathway C3 convertase [3]. Ciprocopan is a deuterated compound, proposed for clinical application in the treatment of pathologies that are driven by hyperactivation of the alternative complement pathway. The structure is claimed in patents held by Tibet Haisco Pharmaceutical [2], and reported by IUPAC name in [1] as the clinical candidate HSK39297.
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
|||||||||||||||||||||||||||||||||||
| Selectivity at enzymes | ||||||||||||||||||||||||||||||||||
| Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||